BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC

<p>SAN DIEGO, Nov. 28, 2023 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced it will host a virtual KOL Event on Monday, December 4, 2023 at 11:00 AM ET. To register, click […]</p>
<p>The post <a href="https://forextv.com/top-news/bioatla-to-host-virtual-kol-event-to-review-iaslc-data-on-ba3011-in-nsclc/">BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>